Failure to Monitor and Care Plan Anticoagulant Use
Penalty
No penalty information released
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Summary
A resident was admitted to the facility and had a physician's order for dabigatran etexilate mesylate, an anticoagulant, to be administered twice daily. Review of the resident's clinical record showed there was no documentation that the resident was monitored for side effects associated with the medication, such as abnormal bleeding or bruising, nor was there evidence that the use of the anticoagulant was addressed in the resident's care plan. The facility's policy on anticoagulant therapy required monitoring for adverse drug effects and inclusion of anticoagulant use and monitoring in the care plan. The DON confirmed during interview that these actions were not completed for this resident.